$BMY PsiOxus Therapeutics Updates Agreement with Bristol Myers Squibb to Advance their Clinical Stage Immuno-Oncology Collaboration

on April 7, 2021 News and Tags: , , , with 0 comments
Time:
3:00 AM
Symbol:
BMY
Source:
Business Wire News Releases
Read more

$BMY Huyabio International Announces Global Clinical Trial Collaboration With Bristol Myers Squibb In Melanoma

on March 30, 2021 News and Tags: , , , with 0 comments
Time:
8:05 AM
Symbol:
BMY
Source:
PR Newswire
Read more

$BMY European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) as Adjuvant Treatment for Patients with Muscle-Invasive Urothelial Carcinoma

on March 29, 2021 News and Tags: , , , with 0 comments
Time:
6:59 AM
Symbol:
BMY
Source:
Business Wire News Releases
Read more

$BMY U.S. Food and Drug Administration Approves Bristol Myers Squibb’s and bluebird bio’s Abecma (idecabtagene vicleucel), the First Anti-BCMA CAR T Cell Therapy for Relapsed or Refractory Multiple Myeloma

on March 26, 2021 News and Tags: , , , with 0 comments
Time:
10:59 PM
Symbol:
BMY
Source:
Business Wire News Releases
Read more

$BMY Bristol Myers Squibb Announces RELATIVITY-047, a Trial Evaluating Anti-LAG-3 Antibody Relatlimab and Opdivo (nivolumab) in Patients with Previously Untreated Metastatic or Unresectable Melanoma, Meets

on March 25, 2021 News and Tags: , , , with 0 comments
Time:
6:59 AM
Symbol:
BMY
Source:
Business Wire News Releases
Read more

$BMY U.S. Food and Drug Administration (FDA) Accepts Bristol Myers Squibb’s Application for Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

on March 19, 2021 News and Tags: , , , with 0 comments
Time:
6:59 AM
Symbol:
BMY
Source:
Business Wire News Releases
Read more

$BMY Bristol Myers Squibb Announces Dividend

on March 1, 2021 News and Tags: , , , with 0 comments
Time:
4:16 PM
Symbol:
BMY
Source:
Business Wire News Releases
Read more

$BMY Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) in Combination with Cabometyx® (cabozantinib) as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma

on February 26, 2021 News and Tags: , , , with 0 comments
Time:
6:25 AM
Symbol:
BMY
Source:
Business Wire News Releases
Read more

$BMY Bristol Myers Squibb Donates $11 Million to Advance Health Equity

on February 24, 2021 News and Tags: , , , with 0 comments
Time:
7:45 AM
Symbol:
BMY
Source:
3BL Media: Corporate Social Responsibility, Energy and Health News
Read more

$BMY Bristol Myers Squibb to Take Part in the Cowen Virtual 41st Annual Health Care Conference

on February 24, 2021 News and Tags: , , , with 0 comments
Time:
7:10 AM
Symbol:
BMY
Source:
Business Wire News Releases
Read more

$BMY Bristol Myers Squibb and Celgene Issue Notices of Redemption and Partial Redemption of Certain of Their Senior Notes at “Make Whole” Prices

on February 22, 2021 News and Tags: , , , with 0 comments
Time:
6:15 PM
Symbol:
BMY
Source:
Business Wire News Releases
Read more

$BMY R&D’s Lorena Kuri Nominated for People En Español Magazine’s Most Influential Women

on February 22, 2021 News and Tags: , , , with 0 comments
Time:
3:30 AM
Symbol:
BMY
Source:
3BL Media: Corporate Social Responsibility, Energy and Health News
Read more

$BMY Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of Tender Offers for an Aggregate Purchase Price of Up to $4.0 Billion

on February 19, 2021 News and Tags: , , , with 0 comments
Time:
5:04 PM
Symbol:
BMY
Source:
Business Wire News Releases
Read more

$BMY Bristol-Myers Squibb Germany Colleague Joins the COVID-19 Fight

on February 19, 2021 News and Tags: , , , with 0 comments
Time:
4:00 AM
Symbol:
BMY
Source:
3BL Media: Corporate Social Responsibility, Energy and Health News
Read more

$BMY Bristol Myers Squibb Announces Early Participation Results and Early Settlement of Tender Offers for Up to an Aggregate Purchase Price of Up to $4.0 Billion

on February 18, 2021 News and Tags: , , , with 0 comments
Time:
9:29 PM
Symbol:
BMY
Source:
Business Wire News Releases
Read more